Monoclonal Antibody Therapies for High Risk Neuroblastoma

Overview of attention for article published in Biologics: Targets & Therapy, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity

Preprint in bioRxiv (March 2024)

Partial Response to Naxitamab for Brain Metastasis in Neuroblastoma

Article in Journal of Pediatric Hematology/Oncology (January 2024)

A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity

Preprint in bioRxiv (January 2024)